372 related articles for article (PubMed ID: 31787568)
81. Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
Chang CC; Cheng AC; Devitt B; Hughes AJ; Campbell P; Styles K; Low J; Athan E
J Hosp Infect; 2008 May; 69(1):33-8. PubMed ID: 18394753
[TBL] [Abstract][Full Text] [Related]
82. Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma.
Stemler J; Koehler P; Maurer C; Müller C; Cornely OA
Ann Hematol; 2020 Jul; 99(7):1429-1440. PubMed ID: 32514626
[TBL] [Abstract][Full Text] [Related]
83. Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis.
Calmettes C; Gabriel F; Blanchard E; Servant V; Bouchet S; Kabore N; Forcade E; Leroyer C; Bidet A; Latrabe V; Leguay T; Vigouroux S; Tabrizi R; Breilh D; Accoceberry I; de Lara MT; Pigneux A; Milpied N; Dumas PY
Oncotarget; 2018 Jun; 9(42):26724-26736. PubMed ID: 29928481
[TBL] [Abstract][Full Text] [Related]
84. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.
Pokala HR; Leonard D; Cox J; Metcalf P; McClay J; Siegel J; Winick N
Pediatr Blood Cancer; 2014 Feb; 61(2):276-80. PubMed ID: 23970381
[TBL] [Abstract][Full Text] [Related]
85. Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections.
Furuno JP; Tallman GB; Noble BN; Bubalo JS; Forrest GN; Lewis JS; Bienvenida AF; Holmes CA; Weber BR; McGregor JC
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012757
[TBL] [Abstract][Full Text] [Related]
86. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
Hachem R; Assaf A; Numan Y; Shah P; Jiang Y; Chaftari AM; Raad II
Int J Antimicrob Agents; 2017 Sep; 50(3):384-388. PubMed ID: 28694233
[TBL] [Abstract][Full Text] [Related]
87. Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis.
Wingen-Heimann SM; Cornely OA; Vehreschild MJGT; Wisplinghoff H; Franke B; Schons M; von Bergwelt-Baildon M; Scheid C; Vehreschild JJ
Mycoses; 2021 Apr; 64(4):437-444. PubMed ID: 33354800
[TBL] [Abstract][Full Text] [Related]
88. Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.
Mattiuzzi G; Yilmaz M; Kantarjian H; Borthakur G; Konopleva M; Jabbour E; Brown Y; Pierce S; Cortes J
J Infect Chemother; 2015 Sep; 21(9):663-7. PubMed ID: 26141814
[TBL] [Abstract][Full Text] [Related]
89. Should patients with acute myeloid leukemia treated with venetoclax-based regimens receive antifungal prophylaxis?
Guarana M; Nucci M
Leuk Res; 2023 Aug; 131():107341. PubMed ID: 37327641
[TBL] [Abstract][Full Text] [Related]
90. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
91. Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses.
Tverdek FP; Heo ST; Aitken SL; Granwehr B; Kontoyiannis DP
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507111
[TBL] [Abstract][Full Text] [Related]
92. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
93. Posaconazole: an extended-spectrum triazole antifungal agent.
Schiller DS; Fung HB
Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
[TBL] [Abstract][Full Text] [Related]
94. Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients.
Peterson L; Ostermann J; Rieger H; Ostermann H; Rieger CT
Mycoses; 2013 Nov; 56(6):651-8. PubMed ID: 23710592
[TBL] [Abstract][Full Text] [Related]
95. Effective protection of allogeneic stem cell recipients against Aspergillosis by HEPA air filtration during a period of construction--a prospective survey.
Krüger WH; Zöllner B; Kaulfers PM; Zander AR
J Hematother Stem Cell Res; 2003 Jun; 12(3):301-7. PubMed ID: 12857371
[TBL] [Abstract][Full Text] [Related]
96. Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis.
Heimann SM; Cornely OA; Vehreschild MJ; Glossmann J; Kochanek M; Kreuzer KA; Hallek M; Vehreschild JJ
Mycoses; 2014 Feb; 57(2):90-7. PubMed ID: 23790060
[TBL] [Abstract][Full Text] [Related]
97. Neutropenia-related aspergillosis in non-transplant haematological patients hospitalised under ambient air versus purified air conditions.
Friese C; Breuckmann K; Hüttmann A; Eisele L; Dührsen U
Mycoses; 2023 Jun; 66(6):505-514. PubMed ID: 36786491
[TBL] [Abstract][Full Text] [Related]
98. Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?
Dragonetti G; Criscuolo M; Fianchi L; Pagano L
Med Mycol; 2017 Jan; 55(1):82-86. PubMed ID: 27915304
[TBL] [Abstract][Full Text] [Related]
99. Posaconazole prophylaxis in patients with acute myelogenous leukaemia--results from an observational study.
Egerer G; Geist MJ
Mycoses; 2011 Jan; 54 Suppl 1():7-11. PubMed ID: 21126266
[TBL] [Abstract][Full Text] [Related]
100. Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients.
Loschi M; Thill C; Gray C; David M; Bagatha MF; Chamseddine A; Contentin N; Jardin F; Lanic H; Lemasle E; Lenain P; Stamatoullas A; Tilly H; Lepretre S
Mycopathologia; 2015 Jun; 179(5-6):337-45. PubMed ID: 25637199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
